Inhibikase Therapeutics Inc (IKT)

Stockholders Equity

$153.33M

Quarterly · Period ending: · USD

IKT logo

IKT Stockholders Equity

Latest reported$153.33M
IKT Quarterly Shareholders Equity (-$1.35M → $153.33M)
High-resolution chart · PNG

IKT stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Inhibikase Therapeutics Inc Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
153,328,586
167,620,268
172,903,679
72,898,298
80,053,685
85,730,671
94,866,280
-530,591
5,096,649
6,776,651
10,977,922
15,017,883
19,464,379
25,321,023
21,035,401
25,136,199
29,502,147
34,009,318
38,415,549
43,161,479
47,054,352
8,036,571
9,784,356
-5,125,056
-4,830,629
-4,701,834
-4,490,016
-777,965
-777,965
-1,399,419
-1,441,008
-1,351,710
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.